Signal2026-07-14
ClinicalTrials.gov

[PHASE1] Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

Part of

Antigen Modification And Immune Dynamics

Open primary sourceSee the whole picture